BioCryst Pharmaceuticals

ISIN US09058V1035

 | 

WKN 896047

Market cap (in EUR)
1 952 M
Country
États-Unis
Sector
Santé
Dividend yield
0,00%
 

Overview

Description

BioCryst Pharmaceuticals, Inc. est une société de biotechnologie. Elle se consacre à la conception de médicaments guidés par la structure dans le but de développer des petites molécules et des protéines thérapeutiques orales pour cibler les maladies rares difficiles à traiter. La société a été fondée par William M. Spencer III, Charles E. Bugg et John A. Montgomery en 1986 et son siège social se trouve à Durham, NC.
Show more Show less
Santé Produits biopharmaceutiques Produits biopharmaceutiques systémiques États-Unis

Financials

Key metrics

Market capitalisation, EUR 1 952 M
EPS, EUR 1,07
P/B ratio -
P/E ratio 7,4
Dividend yield 0,00%

Income statement (2025)

Revenue, EUR 775 M
Net income, EUR 234 M
Profit margin 30,16%

What ETF is BioCryst Pharmaceuticals in?

There are 4 ETFs which contain BioCryst Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of BioCryst Pharmaceuticals is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0,19%
Equity
United States
Health Care
Biotech
45
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0,00%
Equity
World
Social/Environmental
508
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0,00%
Equity
North America
Social/Environmental
25
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0,03%
Equity
United States
Small Cap
201
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.